PenderFund Capital Management’s 2seventy bio TSVT Stock Holding History

PenderFund Capital Management’s Portfolio TSVT Stock Details TSVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-71,600	Closed	-$17.1K	–	177
2025 Q1	$17.1K	Buy	+71,600	New	+$227K	﹤0.01%	119

Other funds holding TSVT

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

PenderFund Capital Management's TSVT Position: Q2 2025 in Review

PenderFund Capital Management sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 71,600 shares — an estimated $17.1K sold.

PenderFund Capital Management first reported a position in TSVT in Q1 2025 and held it in 1 quarter. The position peaked at $17.1K in Q1 2025. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

PenderFund Capital Management reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
PenderFund Capital Management sold 71,600 2seventy bio shares in Q2 2025, an estimated $17.1K.
PenderFund Capital Management first reported a position in 2seventy bio in Q1 2025 and held it in 1 quarter.
PenderFund Capital Management's 2seventy bio position peaked at $17.1K in Q1 2025.
2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on PenderFund Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.